BREAKING: Johnson & Johnson targets newborns, infants, and pregnant women next for COVID vaccine trials | NaturalHealth365

covid-vaccine-trials

by: Sara Middleton, staff writer | March 13, 2021

(NaturalHealth365) On February 26, 2021, the pharmaceutical company and COVID vaccine maker Johnson and Johnson (of Janssen Biotech, Inc.) held an advisory committee briefing with their sponsors.  In the briefing (page 34), they outlined their plans to test their investigational viral vector vaccine, Ad26.COV2.S, in an upcoming cohort of participants.